Novanta (NASDAQ:NOVT – Get Free Report) updated its fourth quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.910-0.960 for the period, compared to the consensus estimate of 1.020. The company issued revenue guidance of $306.0 million-$312.0 million, compared to the consensus revenue estimate of $308.6 million. Novanta also updated its FY 2026 guidance to 3.660-3.710 EPS.
Analyst Upgrades and Downgrades
NOVT has been the topic of several research reports. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a research report on Saturday. Robert W. Baird set a $194.00 price target on Novanta in a research report on Friday, August 7th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Tuesday, October 13th. Finally, Zacks Research downgraded Novanta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Novanta currently has an average rating of “Hold” and an average price target of $194.00.
Check Out Our Latest Report on Novanta
Novanta Stock Performance
NASDAQ NOVT opened at $145.98 on Tuesday. The stock’s fifty day moving average is $142.25 and its two-hundred day moving average is $142.59. The firm has a market capitalization of $5.52 billion, a P/E ratio of 93.58 and a beta of 1.71. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.79 and a current ratio of 4.57. Novanta has a fifty-two week low of $98.27 and a fifty-two week high of $176.38.
Novanta (NASDAQ:NOVT – Get Free Report) last issued its earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.08. Novanta had a return on equity of 10.83% and a net margin of 6.00%. The company had revenue of $305.01 million during the quarter, compared to analysts’ expectations of $301.02 million. During the same period in the prior year, the business earned $0.87 EPS. The firm’s quarterly revenue was up 23.1% on a year-over-year basis. On average, research analysts anticipate that Novanta will post 3.70 earnings per share for the current year.
Novanta Company Profile
Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.
The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.
Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.
Read More
- Five stocks we like better than Novanta
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
